• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN FLX?; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635WU50350
Medical Device Problem Code Failure to Seal (4070)
Health Effect - Clinical Code Chest Pain (1776)
Date of Event 06/25/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
B3 date of event: estimated as 06/25/2025 as the published date for the article is noted as 25 june 2025.D4 unique identifier (udi) #: detailed product information was not provided to bsc as this event was reported via a literature article.This event may represent a duplicate of an event which was already known to boston scientific.Because the product information is unknown at this time, we are unable to provide the complete unique identifier (udi) # and other product specific information.If additional details become available, a supplemental report will be submitted.Literature citation: dahou, a, tran, n, dal-bianco, j.Et al.(2025).Usefulness of echocardiography contrast agents for the detection of residual leak after percutaneous laa closure device implantation.J am coll cardiol case rep.Jun 30 (16).Https://doi.Org/10.1016/j.Jaccas.2025.104197.
 
Event or Problem Description
Reported via literature article.It was reported the device did not seal.Preprocedural transthoracic echocardiography (tte) showed a markedly enlarged left atrium (la), preserved left ventricular ejection fraction (69%), and mild mitral regurgitation.Transesophageal echocardiography (tee) showed no thrombus in the left atrial appendage (laa) or the la.The patient underwent percutaneous left atrial appendage closure (laac) through the implantation of a 35mm watchman flx closure device.Immediate postprocedural transesophageal echocardiography (tee) imaging showed a well-seated watchman device with no residual leak.A follow-up tee performed 10 weeks after device implantation was unremarkable, with no residual leak or thrombus, and anticoagulation therapy was stopped.Subsequent tee was performed 17 months after device implantation, due to abnormal gap around the device noted on cardiac computed tomography done for chest pain.Tee findings were suspicious for a residual leak by color doppler, but a definite diagnosis could not be made.An echo contrast agent was then used, which clearly showed a residual leak around the device located at the lateral aspect of the appendage (at 0 degrees), with opacification of a pouch-like area at the distal aspect of the laa underneath the watchman device, highlighting a communication between the laa and la.These findings helped establish a definite diagnosis of residual leak around the watchman device, which helped guide further management, with the decision to maintain anticoagulation and the consideration of potential percutaneous closure of the residual leak.After multidisciplinary discussion, the patient underwent successful closure of the residual leak with the implantation of coils and a non-boston scientific vascular plug.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN FLX?
Common Device Name
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key22593998
Report Number2124215-2025-49504
Device Sequence Number18391229
Product Code NGV
UDI-Device Identifier08714729860525
UDI-Public(01)08714729860525
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P130013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Literature,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM635WU50350
Device Catalogue NumberM635WU50350
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/22/2025
Initial Report FDA Received Date07/24/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age78 YR
Patient SexFemale
-
-